Scarica l'app Stockscreener
139.17
1.43%
-2.29
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RGEN Giù?
Forum
Previsione
Precedente Chiudi:
$141.46
Aprire:
$144.58
Volume 24 ore:
307.36K
Relative Volume:
0.27
Capitalizzazione di mercato:
$7.85B
Reddito:
$763.34M
Utile/perdita netta:
$51.40M
Rapporto P/E:
153.20
EPS:
0.9084
Flusso di cassa netto:
$104.46M
1 W Prestazione:
+2.19%
1M Prestazione:
+14.00%
6M Prestazione:
-17.52%
1 anno Prestazione:
+12.06%
Intervallo 1D:
$137.61
$144.58
Intervallo di 1 settimana:
$134.68
$144.58
Portata 52W:
$100.99
$175.77
Repligen Corp Stock (RGEN) Company Profile
Nome
Repligen Corp
Settore
Industria
Telefono
(781) 449-9560
Indirizzo
41 SEYON STREET, WALTHAM, MA
Compare RGEN vs ISRG, BDX, MDLN, ALC, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
139.19 | 7.98B | 763.34M | 51.40M | 104.46M | 0.9084 |
ISRG
Intuitive Surgical Inc
|
426.39 | 153.29B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
157.37 | 42.86B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
42.98 | 36.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.04 | 33.32B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
218.66 | 31.68B | 5.54B | 1.52B | 1.74B | 10.37 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-17 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-10-01 | Iniziato | HSBC Securities | Buy |
| 2025-09-22 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2025-06-24 | Iniziato | Barclays | Overweight |
| 2025-04-29 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | Iniziato | Evercore ISI | In-line |
| 2025-02-10 | Iniziato | TD Cowen | Buy |
| 2024-12-17 | Iniziato | Canaccord Genuity | Hold |
| 2024-11-14 | Iniziato | Wolfe Research | Peer Perform |
| 2024-08-28 | Iniziato | Wells Fargo | Overweight |
| 2024-06-26 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-06-18 | Iniziato | Guggenheim | Neutral |
| 2023-12-04 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-07-20 | Iniziato | Wells Fargo | Overweight |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-03-28 | Iniziato | The Benchmark Company | Buy |
| 2022-12-14 | Iniziato | Deutsche Bank | Hold |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | Iniziato | UBS | Buy |
| 2021-10-14 | Iniziato | Exane BNP Paribas | Outperform |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-30 | Reiterato | H.C. Wainwright | Buy |
| 2020-05-07 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-23 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-11-01 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | Iniziato | SVB Leerink | Outperform |
| 2019-08-28 | Reiterato | First Analysis Sec | Outperform |
| 2019-08-23 | Ripresa | Stephens | Overweight |
| 2019-07-22 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | Aggiornamento | CL King | Neutral → Buy |
| 2018-11-12 | Downgrade | CL King | Buy → Neutral |
| 2018-09-26 | Iniziato | H.C. Wainwright | Neutral |
| 2017-12-08 | Iniziato | Citigroup | Buy |
| 2017-12-05 | Iniziato | JP Morgan | Overweight |
| 2017-11-13 | Iniziato | CL King | Buy |
| 2017-10-02 | Aggiornamento | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | Iniziato | William Blair | Outperform |
| 2017-02-13 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
Mostra tutto
Repligen Corp Borsa (RGEN) Ultime notizie
Evercore Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $160 - Moomoo
RGEN Maintained by Evercore ISI Group -- Price Target Raised to $160 - GuruFocus
Is Repligen Corporation (RGEN) A Good Stock To Buy Now? - Yahoo Finance
Here’s Why Repligen Corp. (RGEN) Fell 28% in Q1 - Insider Monkey
A Look at Repligen Corp (RGEN) After 6.8% Decline -- GF Value $1 - GuruFocus
Insider Sell: Jason Garland Sells Shares of Repligen Corp (RGEN) - GuruFocus
Repligen Corp (RGEN) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Biolife Is Said to Have Drawn Takeover Interest From Repligen - Bloomberg.com
Repligen (RGEN) CFO completes 733-share Rule 10b5-1 stock sale - Stock Titan
A Look at Repligen Corp (RGEN) After 4.9% Gain -- GF Value $175. - GuruFocus
Stock Market Today, June 25: Bio-Techne Surges After Merck KGaA Announces $73-Per-Share Cash Acquisition Offer - The Motley Fool
Form 144 REPLIGEN CORP For: 25 June By Investing.com - Investing.com Australia
[144] REPLIGEN CORP SEC Filing - Stock Titan
Repligen jumps as investors revisit strong Q1 results and bioprocessing recovery outlook - Quiver Quantitative
Repligen Corporation (RGEN) Dropped Following the Earnings Release - Insider Monkey
Repligen Corp (RGEN) Shares Fall 4.1% -- What GF Score of 83 Tel - GuruFocus
Repligen StockLong-term strategy and bioprocessing niche - AD HOC NEWS
Repligen Corporation (RGEN) Slid on Softened Enthusiasm for Life Sciences Tools - Insider Monkey
RGEN Technical Analysis & Stock Price Forecast - Intellectia AI
Repligen Corp (RGEN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Repligen Corp (RGEN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Repligen Corp (RGEN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Repligen Corp (RGEN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Repligen Corp (RGEN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Repligen Corp (RGEN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Repligen Corp (RGEN) Institutional Confidence - TradingKey
Repligen Corp (RGEN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Repligen Corp (RGEN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MFS Mid Cap Growth Series's Repligen Corp(RGEN) Holding History - GuruFocus
RBC Capital Resumes Repligen Corp (RGEN) Stock Coverage. Here’s Its View - Insider Monkey
Billionaire Lee Ainslie’s 5 Stocks with Huge Upside Potential - Insider Monkey
Repligen Corp. Hits Day High with 8.45% Surge in Stock Price - Markets Mojo
Multi Cap Equity Fund's Repligen Corp(RGEN) Holding History - GuruFocus
Repligen Corp (RGEN) Shares Surge 3.8% -- What GF Score of 83 Te - GuruFocus
Repligen Corp (RGEN) Shares Surge 4.0% -- What GF Score of 79 Te - GuruFocus
Repligen (RGEN) down 3.2% since last earnings report: Can it rebound? - MSN
Repligen (RGEN) Down 3.2% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
State Street Small-Cap Equity V.I.S. Fund's Repligen Corp(RGEN) Holding History - GuruFocus
Repligen Corp at William Blair Growth Stock Conference Transcript - GuruFocus
RGEN Assumed by Wolfe Research -- Rating Upgraded to Outperform - GuruFocus
Wolfe Research initiates Repligen stock coverage with outperform rating By Investing.com - Investing.com Australia
Wolfe Research initiates Repligen stock coverage with outperform rating - Investing.com
Repligen Has A Cleaner Recovery Angle, But With High Valuation - Seeking Alpha
Repligen Corp stock (US7607591002): RGEN jumps after strong Nasdaq session - AD HOC NEWS
Repligen Corp (RGEN) Stock Up 8.4% and Still Undervalued -- GF S - GuruFocus
RGENRepligen Corp Stock Price and Quote - Finviz
Repligen's $833 Million Guide: Can Analytics And China Power The Next Leg? - Smartkarma
Repligen Corp Azioni (RGEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.39%
2.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):